257 related articles for article (PubMed ID: 18564693)
1. Treatment of eosinophilia with albendazole.
Insiripong S; Siriyakorn N
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):517-20. PubMed ID: 18564693
[TBL] [Abstract][Full Text] [Related]
2. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
Karunajeewa H; Kelly H; Leslie D; Leydon J; Saykao P; Biggs BA
J Travel Med; 2006; 13(2):84-91. PubMed ID: 16553594
[TBL] [Abstract][Full Text] [Related]
3. Curcumin alleviates eosinophilic meningitis through reduction of eosinophil count following albendazole treatment against Angiostrongylus cantonensis in mice.
Shyu LY; Chang HH; Hsu JD; Lin DP; Teng YH; Lee HH
Parasitology; 2012 Mar; 139(3):358-65. PubMed ID: 22053741
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and diagnostic value of toxocariasis in unknown eosinophilia.
Kwon NH; Oh MJ; Lee SP; Lee BJ; Choi DC
Ann Hematol; 2006 Apr; 85(4):233-8. PubMed ID: 16463154
[TBL] [Abstract][Full Text] [Related]
5. [Two outbreaks of eosinophilic meningitis in Yunann (China) clinical, epidemiological and therapeutical issues].
Zhou Z; Barennes H; Zhou N; Ding L; Zhu YH; Strobel M
Bull Soc Pathol Exot; 2009 May; 102(2):75-80. PubMed ID: 19583024
[TBL] [Abstract][Full Text] [Related]
6. Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
Chotmongkol V; Wongjitrat C; Sawadpanit K; Sawanyawisuth K
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):172-4. PubMed ID: 15272765
[TBL] [Abstract][Full Text] [Related]
7. The use of albendazole and diammonium glycyrrhizinate in the treatment of eosinophilic meningitis in mice infected with Angiostrongylus cantonensis.
Li Y; Tang JP; Chen DR; Fu CY; Wang P; Li Z; Wei W; Li H; Dong WQ
J Helminthol; 2013 Mar; 87(1):1-11. PubMed ID: 22152396
[TBL] [Abstract][Full Text] [Related]
8. Angiostrongylus cantonensis: effect of combination therapy with albendazole and dexamethasone on Th cytokine gene expression in PBMC from patients with eosinophilic meningitis.
Diao Z; Chen X; Yin C; Wang J; Qi H; Ji A
Exp Parasitol; 2009 Sep; 123(1):1-5. PubMed ID: 19559022
[TBL] [Abstract][Full Text] [Related]
9. [Food allergy in asthma. Diagnostic significance of peripheral eosinophils].
Longo G; Scornavacca G; Strinati R; Poli F
Pediatr Med Chir; 1987; 9(6):663-8. PubMed ID: 3444741
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis.
Singthong S; Intapan PM; Wongsaroji T; Maleewong W
Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():32-4. PubMed ID: 17547048
[TBL] [Abstract][Full Text] [Related]
11. Resolution of eosinophilia after treatment of cutaneous gnathostomiasis.
Kraivichian K; Nuchprayoon S; Siriyasatien P; Saksirisamphan W; Nuchprayoon I
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S163-6. PubMed ID: 16623022
[TBL] [Abstract][Full Text] [Related]
12. Albendazole therapy for solitary persistent cysticercus granuloma.
Thussu A; Arora A; Lal V; Prabhakar S; Sawhney IM
Neurol India; 2001 Mar; 49(1):95-7. PubMed ID: 11303254
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous gnathostomiasis with ivermectin.
Kraivichian K; Nuchprayoon S; Sitichalernchai P; Chaicumpa W; Yentakam S
Am J Trop Med Hyg; 2004 Nov; 71(5):623-8. PubMed ID: 15569795
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ivermectin and albendazole treatment for gnathostomiasis.
Nontasut P; Bussaratid V; Chullawichit S; Charoensook N; Visetsuk K
Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):374-7. PubMed ID: 11127342
[TBL] [Abstract][Full Text] [Related]
15. Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis.
Nontasut P; Claesson BA; Dekumyoy P; Pakdee W; Chullawichit S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):650-2. PubMed ID: 16124432
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a new therapeutic regimen with albendazole in cutaneous larva migrans.
Veraldi S; Rizzitelli G
Eur J Dermatol; 1999; 9(5):352-3. PubMed ID: 10417435
[TBL] [Abstract][Full Text] [Related]
17. Albendazole in the treatment of strongyloidiasis.
Pungpak S; Bunnag D; Chindanond D; Radmoyos B
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):207-10. PubMed ID: 3672182
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prednisolone plus albendazole with prednisolone alone for treatment of patients with eosinophilic meningitis.
Chotmongkol V; Kittimongkolma S; Niwattayakul K; Intapan PM; Thavornpitak Y
Am J Trop Med Hyg; 2009 Sep; 81(3):443-5. PubMed ID: 19706911
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance.
Brigden M; Graydon C
Arch Pathol Lab Med; 1997 Sep; 121(9):963-7. PubMed ID: 9302929
[TBL] [Abstract][Full Text] [Related]
20. Albendazole therapy for coagulation abnormality in children with eosinophilia.
Xu LH; Fang JP; Zhang LN; Weng WJ; Huang K; Guo HX
Pediatr Hematol Oncol; 2012 May; 29(4):354-7. PubMed ID: 22568798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
